Garen Bohlin - Director at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Garen Bohlin - trading volume in the past year for Karyopharm Therapeutics Inc.

Holdings reported by Garen Bohlin for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 45,140 $37 K $0.82 Sep 12, 2023 Direct
Nonstatutory Stock Option (right to buy) 69,000 May 29, 2024 Direct Common Stock

Transactions reported by Garen Bohlin for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership